MDedge Cardiocast

Find more podcasts from MDedge on our website: https://www.mdedge.com/podcasts

This week's top stories in cardiology:

1. Risk score developed for cardiac-device infection
2. AFib screening cuts hospitalizations and ED visits
3. Arsenic exposure increases risk of left ventricular hypertrophy
4. Ankylosing spondylitis patients taking COX-2 inhibitors may see fewer cardiovascular events

You can contact the show be emailing us at [email protected] and you can interact with us on Twitter at @MDedgeCardio

Find more podcasts from MDedge on our website: https://www.mdedge.com/podcasts

This week's top stories in cardiology:

1. Risk score developed for cardiac-device infection
2. AFib screening cuts hospitalizations and ED visits
3. Arsenic exposure increases risk of left ventricular hypertrophy
4. Ankylosing spondylitis patients taking COX-2 inhibitors may see fewer cardiovascular events

You can contact the show be emailing us at [email protected] and you can interact with us on Twitter at @MDedgeCardio

This week's top stories in clinical medicine:

1. Single-center study outlines stoke risk, DOAC type in nonvalvular A-fib patients
2. ACOG guidance addresses cardiac contributors to maternal mortality
3. Higher serum leptin levels associated with PAD
4. Employed physicians now outnumber independent doctors

This week's top stories in clinical cardiology:

1. Long-term antibiotic use may heighten stroke, CHD risk
2. Noninvasive FFRCT called ADVANCE in chest pain assessment
3. Does BMI affect outcomes after ischemic stroke?
4. Cardiac PET/CT can guise CAD therapy.

You can contact the show by emailing us at [email protected] and you can follow us on Twitter at @MDedgeCardio

MDedge Cardiology editor Catherine Hackett hosts a conversation with Bruce Jancin and Mitch Zoler to talk about some of the research from the meeting as well as their general impressions. 

You can contact the show by emailing us at [email protected]. 

This week in cardiology:

1. Plant-based diet lowers risk of heart failure
2. Medical societies endorse tiered certification for U.S. Heart-Valve care
3. Ticagrelor doesn't beat clopidogrel in postfibrinolysis STEMI
4. Cost gap widens between brand-name, generic drugs.

You can contact the show at [email protected]

This week in clinical cardiology.

1. PCI reduces mortality after STEMI in older adults.

2. Canagliflozin lowers kidney failure risk in T2D: CREDENCE.

3. Poor response to statins hikes risk of cardiovascular events.

4. Low LDL cholesterol may increase women’s risk of hemorrhagic stroke

This week in clinical cardiology:

1. Alirocumab reduces both type 1 and 2 MIs.
   
2. Despite failed primary endpoint, MI alert device has predictive value.
   
3. Look for alcohol septal ablation in the next HOCM guideline.
   
4. FDA: Forty ARBs free of nitrosamines.

You can contact the Cardiocast with ideas, suggestions, stories, or questions for Dr. Dwyer by emailing us at [email protected] and you can follow MDedge Cardiology on Twitter at @MDedgeCardio.

This week's top stories in clinical cardiology:

1. Has radial access PCI been overhyped?

2. Hospital TAVR volume matters to patient survival.

3. Studies link TMAO to microbiome, reveal new heart disease target.

4. More chest compression–only CPR leads to increased survival rates.

You can contact the show by emailing us at [email protected] or you can follow MDedge Cardiology on Twitter at @MDedgeCardio.

This week, a novel drug that reverses ticagrelor’s effect looks promising, a new certification process for cardiologists is unveiled, intensive blood pressure monitoring may not help prevent a second stroke, and the FDA cautions against using paclitaxel coated devices.